KYOWA HAK KIRIN (KY4 DU) stock market data APIs
€12.2299
0.01(0.1%)
as of September 15, 2026
Try our APIs with
free plan!
KYOWA HAK KIRIN Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for KY4.DU.
Prev. Close
12.2299
Open
12.2391
High
12.2598
Low
12.2292
52 wk Range
-21.5574-15.2843
Market Cap
13 438 M
EPS
34.44
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get KYOWA HAK KIRIN data using free add-ons & libraries
Get KYOWA HAK KIRIN Fundamental Data
KYOWA HAK KIRIN Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-10-31
- EPS/Forecast: 35.74
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
KYOWA HAK KIRIN News
New
Tech, Oil Concerns Cramp Asian Stock Markets
Asian stock markets turned in a mixed and generally muted Wednesday, as traders watched Persian Gulf PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Achondroplasia Market Analysis Report 2026: Emerging Pipeline Intensifies Competition, Featuring Ascendis Pharma, BioMarin Pharmaceutical, QED Therapeutics (BridgeBio), Novartis, Kyowa Kirin, RIBOMIC
Company Logo Opportunities center on earlier genetic diagnosis, targeted FGFR3 therapies, long-acting CNP analogs and oral inhibitors. Developers can improve access, affordability, adherence and life...
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. President Donald Trump has secured new drug pricing agreements with nine pharmaceutical companies,...
Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans
Strengthens Kyowa Kirin's commitment to expanding access to medicines Reinforces investment in U.S. manufacturing and innovation TOKYO and PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kyowa Kir...
Get KYOWA HAK KIRIN fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
